Unresectable pancreatic adenocarcinoma with full clinical response following chemoradiotherapy

Aksoy E., Ulas M., Colakoglu M. K., Ozer I., Bostanci E. B., Akoglu M.

TURKISH JOURNAL OF SURGERY, vol.31, no.1, pp.49-51, 2015 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 1
  • Publication Date: 2015
  • Doi Number: 10.5152/ucd.2014.2210
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.49-51
  • Eskisehir Osmangazi University Affiliated: No


Locally advanced or metastatic disease is present in 2/3s of patients with pancreatic cancer. Pancreatic cancer patients are assessed as resectable, potentially resectable (borderline) and unresectable according to pre-operative examinations. The chance for operability may be enhanced by using adjuvant-neoadjuvant systemic chemotherapy, radiotherapy or both. The rates of R0 resection may be increased by means of treatment delivered this way. This case report presents a pancreatic adenocarcinoma case that was assessed to be resectable but was identified to be unresectable during surgical exploration, thus received adjuvant chemoradiotherapy. The patient was then re-evaluated, identified as resectable and received pancreaticoduodenectomy.